{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/FBRX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T13:23:00.206Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2865,"canonical_name":"Forte Biosciences, Inc.","cik":"0001419041","uei":null,"lei":null,"duns":null,"ticker":"FBRX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":23},"count":23,"timeline":[{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Riley Antony A — 2026-07-06","url_slug":"/sec/cik-0001339375/4/0001339375-26-000010","accession_number":"0001339375-26-000010","importance":30},{"ts":"2026-07-06","kind":"sec.filing","form_type":"4","title":"4 — Forte Biosciences, Inc. — 2026-07-06","url_slug":"/sec/cik-0001419041/4/0001612842-26-000010","accession_number":"0001612842-26-000010","importance":30},{"ts":"2026-07-01","kind":"sec.insider.f","reporter":"Riley Antony A","title":"CHIEF FINANCIAL OFFICER","shares":134,"price_per_share":21.32,"usd_value":2857,"security_title":"Common Stock","importance":15.00285688},{"ts":"2026-07-01","kind":"sec.insider.f","reporter":"Wagner Paul A.","title":"SEE REMARKS","shares":98,"price_per_share":21.32,"usd_value":2089,"security_title":"Common Stock","importance":15.00208936},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Riley Antony A","title":"CHIEF FINANCIAL OFFICER","shares":375,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Wagner Paul A.","title":"SEE REMARKS","shares":1250,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Forte Biosciences, Inc. — 2026-06-17","url_slug":"/sec/cik-0001419041/4/0001612842-26-000008","accession_number":"0001612842-26-000008","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Forte Biosciences, Inc. — 2026-06-10","url_slug":"/sec/cik-0001419041/effect/9999999995-26-001951","accession_number":"9999999995-26-001951","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — Forte Biosciences, Inc. — 2026-06-08","url_slug":"/sec/cik-0001419041/s-3-a/0001193125-26-260329","accession_number":"0001193125-26-260329","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/8-k/0001193125-26-253436","accession_number":"0001193125-26-253436","importance":35},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/4/0001480111-26-000002","accession_number":"0001480111-26-000002","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/4/0001814653-26-000002","accession_number":"0001814653-26-000002","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/4/0001863614-26-000002","accession_number":"0001863614-26-000002","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/4/0002038311-26-000002","accession_number":"0002038311-26-000002","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"S-3","title":"S-3 — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/s-3/0001193125-26-253668","accession_number":"0001193125-26-253668","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"S-8","title":"S-8 — Forte Biosciences, Inc. — 2026-06-02","url_slug":"/sec/cik-0001419041/s-8/0001193125-26-253568","accession_number":"0001193125-26-253568","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Forte Biosciences, Inc. — 2026-05-15","url_slug":"/sec/cik-0001419041/schedule-13g/0001687078-26-000011","accession_number":"0001687078-26-000011","importance":55},{"ts":"2026-05-15","kind":"sec.13dg","reporter":"ALGER ASSOCIATES INC","shares":624286,"percent_of_class":10.2,"security_title":"SCHEDULE 13G/A","accession_number":"0001193125-26-226630","excerpt":null,"importance":55},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Forte Biosciences, Inc. — 2026-05-15","url_slug":"/sec/cik-0001419041/schedule-13g-a/0000919574-26-003497","accession_number":"0000919574-26-003497","importance":30},{"ts":"2026-05-14","kind":"sec.filing","form_type":"8-K","title":"8-K — Forte Biosciences, Inc. — 2026-05-14","url_slug":"/sec/cik-0001419041/8-k/0001193125-26-224214","accession_number":"0001193125-26-224214","importance":35},{"ts":"2026-05-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Forte Biosciences, Inc. — 2026-05-14","url_slug":"/sec/cik-0001419041/schedule-13g-a/0001011438-26-000316","accession_number":"0001011438-26-000316","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Forte Biosciences, Inc. — 2026-05-13","url_slug":"/sec/cik-0001419041/schedule-13g/0000919574-26-002927","accession_number":"0000919574-26-002927","importance":55},{"ts":"2026-05-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Forte Biosciences, Inc. — 2026-05-11","url_slug":"/sec/cik-0001419041/10-q/0001193125-26-215862","accession_number":"0001193125-26-215862","importance":45}]}